These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhaled antimicrobial chemotherapy for respiratory tract infections: successes, challenges and the road ahead. Chan HK; Li J Adv Drug Deliv Rev; 2015 May; 85():v-vii. PubMed ID: 25907147 [No Abstract] [Full Text] [Related]
6. Challenges and strategies in drug delivery systems for treatment of pulmonary infections. Ho DK; Nichols BLB; Edgar KJ; Murgia X; Loretz B; Lehr CM Eur J Pharm Biopharm; 2019 Nov; 144():110-124. PubMed ID: 31493510 [TBL] [Abstract][Full Text] [Related]
7. Delivery of antibiotics to the respiratory tract: an update. Traini D; Young PM Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984 [TBL] [Abstract][Full Text] [Related]
8. Inhaled ciprofloxacin for chronic airways infections caused by Pseudomonas aeruginosa. Antonela Antoniu S Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1439-46. PubMed ID: 23253321 [TBL] [Abstract][Full Text] [Related]
9. The false dichotomy of viral versus bacterial aetiology in upper respiratory tract infections. Davis JS; Magin PJ; van Driel ML Med J Aust; 2019 Aug; 211(3):108-109.e1. PubMed ID: 31232463 [No Abstract] [Full Text] [Related]
10. Pulmonary drug delivery systems for antimicrobial agents: facts and myths. Falagas ME; Michalopoulos A; Metaxas EI Int J Antimicrob Agents; 2010 Feb; 35(2):101-6. PubMed ID: 19939637 [TBL] [Abstract][Full Text] [Related]
11. Targeted drug delivery to the virus-infected airway; complications and remedies. Clarke DT; McMillan NA Curr Drug Deliv; 2015; 12(1):86-97. PubMed ID: 25233122 [TBL] [Abstract][Full Text] [Related]
12. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Zumla A; Memish ZA; Maeurer M; Bates M; Mwaba P; Al-Tawfiq JA; Denning DW; Hayden FG; Hui DS Lancet Infect Dis; 2014 Nov; 14(11):1136-1149. PubMed ID: 25189352 [TBL] [Abstract][Full Text] [Related]
14. Local treatment of respiratory infections with antibiotics. Stout SA; Derendorf H Drug Intell Clin Pharm; 1987 Apr; 21(4):322-9. PubMed ID: 3552545 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature. Sherwin J; Heath T; Watt K Clin Ther; 2016 Sep; 38(9):1976-94. PubMed ID: 27553752 [TBL] [Abstract][Full Text] [Related]
16. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults. Kaiser L; Keene ON; Hammond JM; Elliott M; Hayden FG Arch Intern Med; 2000 Nov; 160(21):3234-40. PubMed ID: 11088083 [TBL] [Abstract][Full Text] [Related]
17. Inhaled antibiotics for gram-negative respiratory infections. Hudson R; Olson Blair B Future Med Chem; 2011 Oct; 3(13):1663-77. PubMed ID: 21942255 [TBL] [Abstract][Full Text] [Related]